Drug recall

Apheresis Platelets, Leukocytes Reduced

FDA recall event 80988 · Class II · Belle Bonfils Memorial Blood Center

Key facts

Event ID 80988
Recall numbers B-0805-2018
Recalling firm Belle Bonfils Memorial Blood Center
Product type Biologics
Products Apheresis Platelets, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Apheresis product, in which platelet yield did not meet specifications, was distributed.
Initiation date Jul 29, 2018
Report date Sep 26, 2018
Termination date Sep 17, 2018
City Denver
State CO
Country United States
FEI number 3000210247

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls